Nautilus Biotechnology, Inc. (NAUT) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Biotecnología industria. La empresa tiene su sede en Seattle, WA, United States. El CEO actual es Sujal Patel.
NAUT tiene fecha de IPO 2020-08-07, 134 empleados a tiempo completo, cotiza en el NASDAQ Global Select, una capitalización de mercado de $387.29M.
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is headquartered in Seattle, Washington.
